Dynamic hydrazone crosslinked salecan/chondroitin sulfate hydrogel platform as a promising wound healing Strategy: A comparative study on antibiotic and probiotic delivery.
Int J Pharm
; 665: 124667, 2024 Nov 15.
Article
en En
| MEDLINE
| ID: mdl-39241931
ABSTRACT
Natural polysaccharide-based active-ingredient carriers have been a source of great concern for a long time. In order to explore potential antibiotics and probiotics carriers, a novel injectable chondroitin sulfate/salecan (CS) hydrogel was constructed by forming dynamic hydrazone bonds. Scanning electron microscope (SEM), proton nuclear magnetic resonance (1H NMR), Fourier transform infrared spectroscopy (FTIR), bacteriostatic test, and rheological experiments were used to investigate the chemical structure, inherent morphology, and enzymatic corruption of the hydrogel in vitro. The resulting hydrogels exhibited ideal probiotics loading capacity, drug release behavior, excellent antimicrobial activity and variable properties. Crucially, owing to its exceptional biocompatibility and reversible crosslinking network, this hydrogel can function as a three-dimensional extracellular matrix for cells, enabling cells to maintain high vitality and proliferation, and promote wound healing. The aforementioned findings indicated that this novel hydrogel can be a promising candidate as an active-ingredient carrier and scaffold material for tissue engineering.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Cicatrización de Heridas
/
Sulfatos de Condroitina
/
Probióticos
/
Hidrogeles
/
Liberación de Fármacos
/
Hidrazonas
/
Antibacterianos
Idioma:
En
Revista:
Int J Pharm
/
Int. j. pharm
/
International journal of pharmaceutics
Año:
2024
Tipo del documento:
Article